August 6th 2025
Take a look through key stories from last month, including regulatory news, trial updates, and other practice-changing advancements.
Study highlights gender and racial disparities in receiving optimal treatment for kidney cancer
July 21st 2021“To our knowledge, this study represents the first attempt to assess the associations between demographic factors and receipt of non–guideline-based treatment among patients with kidney cancer,” the authors of the study wrote.
Neoadjuvant stereotactic ablative radiation shows promise for invasive renal cell carcinoma
July 2nd 2021Neoadjuvant stereotactic ablative radiation followed by radical nephrectomy and thrombectomy was safe and showed signs of positive clinical activity in patients with renal cell carcinoma and inferior vena cava tumor thrombus.
Study supports routine brain imaging at baseline in metastatic kidney cancer
April 19th 2021"Brain imaging is routinely obtained for kidney cancer patients with symptoms that suggest CNS metastases, but none of the patients with brain metastases included here were symptomatic," said Martin H. Voss, MD.
Dr. Primo Lara on the need for multidisciplinary care in kidney cancer
March 30th 2021Dr. Primo Lara, Jr., executive associate dean for Cancer Programs, School of Medicine, at UC Davis Comprehensive Cancer Center, highlights the need for personalized medicine using multidisciplinary care for patients with renal cell carcinoma.